The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Abstract
Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (T R cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs, which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4 + CD25 + T R cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Self-citationApproaching the Asymptote? Evolution and Revolution in Immunology
Janeway, C. A. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,252
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434
Self-citationSakaguchi, S. (2000) · Cell · doi:10.1016/s0092-8674(00)80856-9 · Cited by 1,815
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Cited by
Items 201–257 of 257
McKinstry, K. K., Strutt, T. M., Buck, A., Curtis, J. D., Dibble, J. P., Huston, G., Tighe, M., Hamada, H., Sell, S., Dutton, R. W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900657 · Cited by 287
Rolland, A., Jouvin-Marche, E., Viret, C., Faure, M., Perron, H., & Marche, P. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7636 · Cited by 287
The functional plasticity of T cell subsets
Bluestone, J. A., Mackay, C. R., O'Shea, J. J., & Stockinger, B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2654 · Cited by 285
Pandiyan, P., Conti, H. R., Zheng, L., Peterson, A. C., Mathern, D. R., Hernández-Santos, N., Edgerton, M., Gaffen, S. L., & Lenardo, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.002 · Cited by 281
Hersoug, L. ‐., & Linneberg, A. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01506.x · Cited by 281
The Control of Adaptive Immune Responses by the Innate Immune System
Schenten, D., & Medzhitov, R. (2011) · Advances in Immunology · doi:10.1016/b978-0-12-387664-5.00003-0 · Cited by 279
Self-citationCD86 and CD80 Differentially Modulate the Suppressive Function of Human Regulatory T Cells
Zheng, Y., Manzotti, C. N., Liu, M., Burke, F., Mead, K. I., & Sansom, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2778 · Cited by 279
Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders
Rook, G. A. W., Adams, V., Palmer, R., Brunet, L. R., Hunt, J., & Martinelli, R. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0148-9 · Cited by 278
Godfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood-2004-01-0151 · Cited by 277
Petermann, F., Rothhammer, V., Claussen, M. C., Haas, J. D., Blanco, L. R., Heink, S., Prinz, I., Hemmer, B., Kuchroo, V. K., Oukka, M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.013 · Cited by 275
Regulatory T cells and intestinal homeostasis
Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H., & Powrie, F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00250.x · Cited by 275
Ghiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
Zhou, G., Drake, C. G., & Levitsky, H. I. (2006) · Blood · doi:10.1182/blood-2005-07-2737 · Cited by 272
Th17 T cells: Linking innate and adaptive immunity
Stockinger, B., Veldhoen, M., & Martin, B. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.008 · Cited by 271
Savarese, E., Chae, O.-W., Trowitzsch, S., Weber, G., Kastner, B., Akira, S., Wagner, H., Schmid, R. M., Bauer, S., & Krug, A. (2006) · Blood · doi:10.1182/blood-2005-07-2650 · Cited by 271
Lugo-Villarino, G., Maldonado-López, R., Possemato, R., Peñaranda, C., & Glimcher, L. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332767100 · Cited by 271
Immunomodulatory Properties of Defensins and Cathelicidins
Bowdish, D. M. E., Davidson, D. J., & Hancock, R. E. W. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-29916-5_2 · Cited by 269
Shen, L., Evel-Kabler, K., Strube, R., & Chen, S.-Y. (2004) · Nature Biotechnology · doi:10.1038/nbt1035 · Cited by 267
CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells
Makita, S., Kanai, T., Oshima, S., Uraushihara, K., Totsuka, T., Sawada, T., Nakamura, T., Koganei, K., Fukushima, T., & Watanabe, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3119 · Cited by 264
McKee, A. S., & Pearce, E. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1224 · Cited by 262
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Regulatory T cells in systemic lupus erythematosus
Ohl, K., & Tenbrock, K. (2015) · European Journal of Immunology · doi:10.1002/eji.201344280 · Cited by 262
Håkansson, Å., Tormo-Badia, N., Baridi, A., Xu, J., Molin, G., Hagslätt, M.-L., Karlsson, C., Jeppsson, B., Cilio, C. M., & Ahrné, S. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0270-5 · Cited by 262
Regulatory T cells and inhibitory cytokines in autoimmunity
Bettini, M., & Vignali, D. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.011 · Cited by 258
Preferential expression and function of Toll-like receptor 3 in human astrocytes
Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., & Meinl, E. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.009 · Cited by 256
Impaired regulatory T cell function in germ‐free mice
Östman, S., Rask, C., Wold, A. E., Hultkrantz, S., & Telemo, E. (2006) · European Journal of Immunology · doi:10.1002/eji.200535244 · Cited by 256
Regulatory T cells in virus infections
Rouse, B. T., Sarangi, P. P., & Suvas, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00412.x · Cited by 255
gp130 at the nexus of inflammation, autoimmunity, and cancer
Silver, J. S., & Hunter, C. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410217 · Cited by 254
Hamdy, S., Molavi, O., Ma, Z., Haddadi, A., Alshamsan, A., Gobti, Z., Elhasi, S., Samuel, J., & Lavasanifar, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.035 · Cited by 252
Th17 cells: from precursors to players in inflammation and infection
Awasthi, A., & Kuchroo, V. K. (2009) · International Immunology · doi:10.1093/intimm/dxp021 · Cited by 241
Tumor microenvironment in ovarian cancer: function and therapeutic strategy
Yang, Y., Yang, Y., Yang, J., Zhao, X., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00758 · Cited by 218
Kwan, W.-H., van der Touw, W., Paz-Artal, E., Li, M. O., & Heeger, P. S. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121525 · Cited by 215
“Several groups showed that TLRstimulated APCs upregulate IL6, IL1, and complement protein production, coincident with inhib iting T reg cell function (Pasare and Medzhitov, 2003; Hu et al., 2011; Peng et al., 2006; Zhou et al., 2006), and that the IL6–mediated effects are linked to C5aR in other cell types (Ried…”
BackgroundMethodInfluentialNowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Human regulatory T cells induce T-lymphocyte senescence
Ye, J., Huang, X., Hsueh, E. C., Zhang, Q., Ma, C., Zhang, Y., Varvares, M. A., Hoft, D. F., & Peng, G. (2012) · Blood · doi:10.1182/blood-2012-03-416040 · Cited by 198
Jones, G. W., McLoughlin, R. M., Hammond, V. J., Parker, C. R., Williams, J. D., Malhotra, R., Scheller, J., Williams, A. S., Rose-John, S., Topley, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901528 · Cited by 189
The physiological regulation of toll‐like receptor expression and function in humans
Lancaster, G. I., Khan, Q., Drysdale, P., Wallace, F., Jeukendrup, A. E., Drayson, M. T., & Gleeson, M. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.081224 · Cited by 176
Sawa, S.-I., Kamimura, D., Jin, G.-H., Morikawa, H., Kamon, H., Nishihara, M., Ishihara, K., Murakami, M., & Hirano, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052187 · Cited by 176
Targeting the TLR9–MyD88 pathway in the regulation of adaptive immune responses
Huang, X., & Yang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.501333 · Cited by 121
Lampropoulou, V., Calderon‐Gomez, E., Roch, T., Neves, P., Shen, P., Stervbo, U., Boudinot, P., Anderton, S. M., & Fillatreau, S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00855.x · Cited by 130
Chen, Y., Haines, C. J., Gutcher, I., Hochweller, K., Blumenschein, W. M., McClanahan, T., Hämmerling, G., Li, M. O., Cua, D. J., & McGeachy, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.011 · Cited by 123
Kortylewski, M., Kujawski, M., Herrmann, A., Yang, C., Wang, L., Liu, Y., Salcedo, R., & Yu, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3031 · Cited by 122
“Based on numerous studies in mice demonstrating their efficacy in breaking immune tolerance (3, 4) and promoting Th1-dependent immunity (2), several TLR9 agonists are currently used to treat solid and hematologic malignancies (1).”
Enhanced Th17 phenotype in individuals with generalized anxiety disorder
Vieira, M. M. M., Ferreira, T. B., Pacheco, P. A. F., Barros, P. O., Almeida, C. R. M., Araújo-Lima, C. F., Silva-Filho, R. G., Hygino, J., Andrade, R. M., Linhares, U. C., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.018 · Cited by 118
Nikolic, T., & Roep, B. O. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00113 · Cited by 112
Murine Liver Antigen Presenting Cells Control Suppressor Activity of CD4+CD25+ Regulatory T Cells *
Wiegard, C., Frenzel, C., Herkel, J., Kallen, K.-J., Schmitt, E., & Lohse, A. W. (2005) · Hepatology · doi:10.1002/hep.20756 · Cited by 97
Voltan, S., Castagliuolo, I., Elli, M., Longo, S., Brun, P., D'Incà, R., Porzionato, A., Macchi, V., Palù, G., Sturniolo, G. C., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00079-07 · Cited by 96
GP96 is a GARP chaperone and controls regulatory T cell functions
Zhang, Y., Wu, B. X., Metelli, A., Thaxton, J. E., Hong, F., Rachidi, S., Ansa-Addo, E., Sun, S., Vasu, C., Yang, Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79014 · Cited by 95
“TLRs can modulate responding cells to Treg-mediated suppression (56), but they are not required for steady-state immune tolerance (57), as demonstrated by lack of autoinflammatory disease in Myd88 and Trif double-KO mice, which have abolished all TLR signaling (58). α V integrin is a client of GP96,…”
Torrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., & Pedrosa, J. (2007) · Infection and Immunity · doi:10.1128/iai.00290-07 · Cited by 95
Yang, R., Lirussi, D., Thornton, T. M., Jelley-Gibbs, D. M., Diehl, S. A., Case, L. K., Madesh, M., Taatjes, D. J., Teuscher, C., Haynes, L., et al. (2015) · eLife · doi:10.7554/elife.06376 · Cited by 91
Corticosterone impairs dendritic cell maturation and function
Elftman, M. D., Norbury, C. C., Bonneau, R. H., & Truckenmiller, M. E. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02637.x · Cited by 79
d’Hennezel, E., Yurchenko, E., Sgouroudis, E., Hay, V., & Piccirillo, C. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100269 · Cited by 73
Spinner, D. S., Kascsak, R. B., LaFauci, G., Meeker, H. C., Ye, X., Flory, M. J., Kim, J. I., Schuller-Levis, G. B., Levis, W. R., Wisniewski, T., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106665 · Cited by 54
“In addition, T cell-based mechanisms, including down-regulation of Treg function [21–24, 85], enhanced levels of antigen cross-presentation [98–101], and increased activation of CD8 T cells [86, 102–104] are likely to play important roles in the therapeutic effect of CpG ODNs on scrapie; these effects may be especiall…”
BackgroundFleskens, V., Minutti, C. M., Wu, X., Wei, P., Pals, C. E. G. M., McCrae, J., Hemmers, S., Groenewold, V., Vos, H.-J., Rudensky, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.087 · Cited by 49
Sharma, S., Dominguez, A. L., Hoelzinger, D. B., & Lustgarten, J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0393-1 · Cited by 46
“We believe that the cytokines secreted after CpG-ODN treatment (30 g/injection) inXuence the homeostasis of Tregs in old tumor bearing hosts by preventing de novo conversion of Tregs and inhibiting their suppressing activity [25].”
BackgroundLi, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62948-3 · Cited by 39
Unstable regulatory T cells, enriched for naïve and Nrp1negcells, are purged after fate challenge
Junius, S., Mavrogiannis, A. V., Lemaitre, P., Gerbaux, M., Staels, F., Malviya, V., Burton, O., Gergelits, V., Singh, K., Tito Tadeo, R. Y., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abe4723 · Cited by 30
Ferreira, R. C., Rainbow, D. B., Rubio García, A., Pekalski, M. L., Porter, L., Oliveira, J. J., Waldron-Lynch, F., Wicker, L. S., & Todd, J. A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.002 · Cited by 19
“In addition, studies in mice have also shown that IL-6 signalling is an established factor to inhibit the suppressive function of Tregs [31], although this effect has been shown to be Treg extrinsic, through the activation of Teffs, which are able to escape Treg suppression [32].”
BackgroundThe Changing Microbial Environment and Chronic Inflammatory Disorders
Rook, G. A. W. (2008) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-4-3-117 · Cited by 9
Metadata
- Authors
- Pasare, C., & Medzhitov, R.
- Venue
- Science
- Published
- 2003-02-14
- Volume
- 299
- Issue
- 5609
- Pages
- 1033-1036
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2001740313
- Cited by
- 1,997
- References
- 27
- FWCI
- 60.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.